All changes for the tissue urinary system (67)

Identifier Name Type Tissues Organism Gene Data Actions
DAA267 amyloid beta (A4) precursor protein-binding, family B, member 1 interacting protein Molecular kidney Human APBB1IP 23.0% Increase Gene Expression Level
DAA289 brain protein 44-like Molecular kidney Human BRP44L 9.0% Decrease Gene Expression Level
DAA291 chromosome 1 open reading frame 162 Molecular kidney Human C1orf162 37.0% Increase Gene Expression Level
DAA263 claudin 8 Molecular kidney Human CLDN8 17.0% Decrease Gene Expression Level
DAA281 coiled-coil domain containing 3 Molecular kidney Human CCDC3 19.0% Increase Gene Expression Level
DAA275 complement component 1, q subcomponent, C chain Molecular kidney Human C1QC 27.0% Increase Gene Expression Level
DAA288 complement component 1, r subcomponent Molecular kidney Human C1R 21.0% Increase Gene Expression Level
DAA265 complement component 1, s subcomponent Molecular kidney Human C1S 24.0% Increase Gene Expression Level
DAA287 creatine kinase, brain Molecular kidney Human CKB 10.0% Decrease Gene Expression Level
DAA273 cytoplasmic FMR1 interacting protein 2 Molecular kidney Human CYFIP2 11.0% Decrease Gene Expression Level
DAA1062 Creatinine clearance declines Physiological kidney Human — —
DAA272 dedicator of cytokinesis 11 Molecular kidney Human DOCK11 24.0% Increase Gene Expression Level
DAA256 defensin, beta 1 Molecular kidney Human DEFB1 8.0% Decrease Gene Expression Level
DAA258 EF-hand domain family, member D1 Molecular kidney Human EFHD1 9.0% Decrease Gene Expression Level
DAA271 epidermal growth factor (beta-urogastrone) Molecular kidney Human EGF 25.0% Decrease Gene Expression Level
DAA626 Essential (primary) hypertension and hypertensive renal disease Pathological heart, kidney Human — SeriesMorbidity
DAA604 Cancer of kidney and renal pelvis Pathological urinary system Human — SeriesMorbidity